Drug patents opposed in 2019
Drug patents opposed in 2019 at the European Patent Office (EPO)
| Patent Number | Patent Title | Company | Recent Opposition Date | Recent Opposition By | Activity Alert |
|---|---|---|---|---|---|
| EP2214679B1 | Corticosteroid Compositions | MERITAGE PHARMA INC |
27 Dec, 2019
(Expiration: Nov, 2028)
|
AECHTER
(and 1 more)
| |
| EP2756004B1 | Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9) | REGENERON PHARMACEUTICALS |
27 Dec, 2019
|
AMGEN
(and 1 more)
| |
| EP2772500B1 | Site-Directed Modification Of Fviii | BAYER HEALTHCARE LLC |
27 Dec, 2019
(Expiration: Nov, 2025)
|
MARKS & CLERK
| |
| EP2667892B1 | Rsv Immunization Regimen | GLAXOSMITHKLINE BIOLOGICALS SA |
27 Dec, 2019
(Expiration: Jan, 2032)
|
PFIZER
| |
| EP3041939B1 | Recombinant Marek'S Disease Viruses And Uses Thereof | CEVA SANT ANIMALE |
24 Dec, 2019
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP3067066B1 | Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease | PROTHENA BIOSCIENCES |
24 Dec, 2019
|
EUROPEAN OPPOSITIONS
| |
| EP3038647B1 | Combination Therapy For The Treatment Of Glioblastoma | F HOFFMANN LA ROCHE AG |
23 Dec, 2019
(Expiration: Aug, 2034)
|
AMGEN
(and 1 more)
| |
| EP3056514B1 | Methods For Manipulating Phagocytosis Mediated By Cd47 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
23 Dec, 2019
|
ARCH ONCOLOGY
(and 3 more)
| |
| EP3056515B1 | Methods For Manipulating Phagocytosis Mediated By Cd47 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
23 Dec, 2019
|
ARCH ONCOLOGY
(and 3 more)
| |
| EP3262200B1 | Process For Producing Low Ash Lactose Using A Clarifier With Acid And Device For Carrying Out The Process | SPX FLOW TECHNOLOGY DANMARK |
23 Dec, 2019
|
GEA PROCESS ENGINEERING
| |
| EP2988733B1 | Pharmaceutical Composition Containing Crystalline Macitentan | SANDOZ |
23 Dec, 2019
|
GILL JENNINGS & EVERY
| |
| EP3236938B1 | Oral Topical Aqueous Pharmaceutical Compositions Of Flurbiprofen And Dexpanthenol | SANOVEL ILAC SANAYI VE TICARET AS |
23 Dec, 2019
(Expiration: Dec, 2035)
|
RECKITT BENCKISER HEALTH
| |
| EP2861234B1 | Progesterone Formulations | THERAPEUTICSMD INC |
23 Dec, 2019
(Expiration: Jun, 2033)
|
RIECK
| |
| EP2200588B1 | Compositions Comprising Lipophilic Active Compounds And Method For Their Preparation | SOLUBEST LTD |
20 Dec, 2019
(Expiration: Sep, 2028)
|
DSM NUTRITIONAL PRODUCTS
| |
| EP2356981B1 | Mascara Containing Aqueous Dispersion Of Polyurethane And A Hard Wax | LORAL |
20 Dec, 2019
|
FA SCHWANHUER INDUSTRIE HOLDING
| |
| EP2944323B1 | Agents For Treating Tumours, Use And Method Thereof | DINGFU BIOTARGET CO LTD |
20 Dec, 2019
(Expiration: Jan, 2033)
|
GLAXOSMITHKLINE
(and 2 more)
| |
| EP2569419B1 | Differentiation Of Human Embryonic Stem Cells | JANSSEN BIOTECH INC |
20 Dec, 2019
(Expiration: May, 2031)
|
SANOFI
| |
| EP3185845B1 | Non-Greasy Personal Care Compositions | COLGATE PALMOLIVE |
19 Dec, 2019
|
HENKEL
| |
| EP2252148B1 | Methods For Treating Bowel Diseases | SALIX PHARMACEUTICALS |
19 Dec, 2019
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
(and 2 more)
| |
| EP2754440B1 | Medicinal Agent For Treating Amyotrophic Lateral Sclerosis Or Preventing Progression Of Phase Of Amyotrophic Lateral Sclerosis | MITSUBISHI TANABE PHARMA CORP |
19 Dec, 2019
(Expiration: Sep, 2032)
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
| |
| EP2488044B1 | Allergy Treatment Using Acid Treated Aqueous Whey Protein Extract | DAIRY AUSTRALIA |
18 Dec, 2019
|
NUTRICIA
| |
| EP3165220B1 | Pharmaceutical Composition Containing An Anti-Nucleating Agent | MERCK SHARP & DOHME |
17 Dec, 2019
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
| |
| EP2658513B2 | Hair Colouring Composition | KAO GERMANY |
16 Dec, 2019
|
HENKEL
| |
| EP3351240B1 | Formulations Of 4-Amino-2-(2,6-Dioxopiperidine-3-Yl)Isoindoline-1,3-Dione | CELGENE |
16 Dec, 2019
|
PRU
(and 3 more)
| |
| EP3034093B1 | Compositions And Methods Of Treating Tumors | UNIVERSITY OF PENNSYLVANIA PENN |
13 Dec, 2019
(Expiration: Mar, 2019)
|
F HOFFMANN LA ROCHE
| |
| EP3030666B1 | Compositions And Methods For Treatment Of Muscular Dystrophy | CONSIGLIO NAZIONALE DELLE RICHERCHE CNR |
13 Dec, 2019
(Expiration: Jul, 2034)
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP3165227B2 | Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria | MD HEALTHCARE |
13 Dec, 2019
|
ICOSA EUROPE
| |
| EP3093005B1 | Octocrylene-Free Sunscreen Comprising Diethyl Hexyl Butamido Triazone | BEIERSDORF AG |
13 Dec, 2019
(Expiration: May, 2036)
|
PLOUGMANN VINGTOFT
(and 6 more)
| |
| EP3090780B2 | Process For The Preparation Of An Oil-In-Water Emulsion | DIVA BRANDS & PATENTS |
12 Dec, 2019
|
HENKEL
| |
| EP3092226B1 | Indazole Compounds As Irak4 Inhibitors | AURIGENE DISCOVERY TECHNOLOGIES LTD |
11 Dec, 2019
(Expiration: Jan, 2035)
|
BAYER BAYER PHARMA
| |
| EP1893734B1 | Near Anhydrous Consumer Products Comprising Fragranced Aminoplast Capsules | FIRMENICH SA |
10 Dec, 2019
(Expiration: May, 2026)
|
GIVAUDAN
(and 3 more)
| |
| EP2859075B1 | Biosolubilizer | GIVAUDAN SA |
09 Dec, 2019
(Expiration: May, 2033)
|
CRODA
(and 1 more)
| |
| EP3195853B1 | Octocrylene-Free Solar Protection Formulation With Diethylamino Hydroxybenzoyl Hexyl Benzoate. | BEIERSDORF AG |
09 Dec, 2019
(Expiration: Jan, 2037)
|
EMIL KIESSLING
| |
| EP3103448B1 | Pharmaceutical Compositions Comprising An S1P Modulator | NOVARTIS |
09 Dec, 2019
(Expiration: Sep, 2027)
|
ZENTIVA
(and 6 more)
| |
| EP3300721B1 | Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices | NOVO NORDISK AS |
06 Dec, 2019
(Expiration: Nov, 2024)
|
GENERICS UK
(and 4 more)
| |
| EP2198929B1 | Hair Dye Or Lightening Composition Comprising A Fatty Substance And A Cationic Polymer, And Use Thereof | LOREAL |
06 Dec, 2019
|
HENKEL
| |
| EP3297732B1 | Anhydrous Deodorant Composition Made From Bicarbonate | LABORATOIRES M & L |
06 Dec, 2019
|
HENKEL
| |
| EP3262941B1 | Isothiazolinone Biocides Enhanced By Zinc Ions | ARCH CHEMICALS |
06 Dec, 2019
|
THOR
| |
| EP1633766B1 | Modified Fluorinated Nucleoside Analogues | GILEAD PHARMASSET LLC |
05 Dec, 2019
(Expiration: Apr, 2024)
|
GILLARD
| |
| EP2198927B1 | Composition Comprising A Fatty Substance And A Particular Oxyethylene Surfactant, Dyeing Or Lightening Process Using It, And Devices Therefor | LOREAL |
05 Dec, 2019
|
HENKEL
| |
| EP3047843B1 | First Agent For Oxidation Hair Dye And Method For Stabilizing Color Tone Of Oxidation Hair Dyeing Agent Composition | HOYU |
05 Dec, 2019
|
KAO GERMANY
| |
| EP2922532B1 | 5-Aminosalicylic Acid Capsule Formulation | ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD |
05 Dec, 2019
(Expiration: Nov, 2033)
|
WIBBELMANN
| |
| EP2868318B2 | Injectable Formulation | OTSUKA PHARMACEUTICAL |
04 Dec, 2019
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
| |
| EP2196189B1 | Cosmetic Sunscreen Compositions Based On Synergistic Filter Mixture And Their Use | LOREAL SA |
04 Dec, 2019
(Expiration: Nov, 2022)
|
STADA ARZNEIMITTEL
(and 1 more)
| |
| EP2854746B1 | Composition | COSMETIC WARRIORS |
28 Nov, 2019
|
HENKEL
| |
| EP3182958B2 | Aripiprazole Prodrug Compositions | ALKERMES PHARMA IRELAND |
27 Nov, 2019
|
GENERICS UK
| |
| EP2280687B1 | Chewing Gum Compositions Comprising Cannabinoids | STICHTING SANAMMAD |
27 Nov, 2019
(Expiration: Mar, 2029)
|
MEDCAN PHARMA
| |
| EP3269717B9 | Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104 | PFIZER IRELAND PHARMACEUTICALS |
26 Nov, 2019
(Expiration: Oct, 2030)
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP2658399B2 | Nutritional Compositions Comprising Human Milk Oligosaccharides And Nucleotides And Uses Thereof For Treating And/Or Preventing Enteric Viral Infection | ABBOTT LABORATORIES |
26 Nov, 2019
|
SOCIT DES PRODUITS NESTL
(and 1 more)
| |
| EP3114943B1 | Non-Allergenic Food Product | NUTRICIA NV |
26 Nov, 2019
(Expiration: Aug, 2027)
|
SOCIT DES PRODUITS NESTL
| |
| EP2773361B1 | Method For Improving Executive Function | NUTRICIA |
25 Nov, 2019
|
SOCIT DES PRODUITS NESTL
| |
| EP2711024B1 | Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same | UNITED THERAPEUTICS CORP |
22 Nov, 2019
(Expiration: Sep, 2028)
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
| |
| EP2928496B1 | Crispr-Based Genome Modification And Regulation | SIGMA ALDRICH CO LLC |
22 Nov, 2019
(Expiration: Dec, 2033)
|
VOSSIUS & PARTNER PATENTANWLTE RECHTSANWLTE MBB
(and 7 more)
| |
| EP2939688B1 | Pharmaceutical Compositions Comprising Botulinum Neurotoxin | IPSEN BIOPHARM |
20 Nov, 2019
|
ALLERGAN
| |
| EP3003277B1 | Process For The Preparation Of A Pharmaceutical Composition Comprising Rivaroxaban | SANDOZ AG |
20 Nov, 2019
(Expiration: May, 2034)
|
HGF
| |
| EP2451445B1 | Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active Ingredient | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
20 Nov, 2019
(Expiration: Jul, 2030)
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
| |
| EP2444027B2 | Implant Coated With Net-Shaped Or Island-Shaped Low-Crystallized Hydroxyapatite And Method For Coating Same | OSSTEMIMPLANT |
20 Nov, 2019
|
WYNNE JONES
| |
| EP2527457B1 | Widespread Gene Delivery To Motor Neurons Using Peripheral Injection Of Aav Vectors | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS |
19 Nov, 2019
(Expiration: Oct, 2028)
|
BEZZUBOVA
| |
| EP2481420B1 | Single Dose Anti-Pcv2 Pig Vaccine | BOEHRINGER INGELHEIM ANIMAL HEALTH USA |
19 Nov, 2019
(Expiration: Dec, 2027)
|
CEVA SANTE ANIMALE
(and 1 more)
| |
| EP1622470B1 | Alginate Matrix Particles | GIVAUDAN SA |
19 Nov, 2019
(Expiration: May, 2024)
|
OMYA
| |
| EP1856051B1 | Amorphous Lercanidipine Hydrochloride | RECORDATI IRELAND LTD |
13 Nov, 2019
(Expiration: Feb, 2026)
|
GLENMARK LIFE SCIENCES
(and 6 more)
| |
| EP2886108B2 | Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus | DR FALK PHARMA |
06 Nov, 2019
|
ADARE
| |
| EP3103784B1 | Manufacture Of An Oil-In-Water Emulsion Comprising Squalene | SEQIRUS UK |
06 Nov, 2019
|
GLAXOSMITHKLINE BIOLOGICALS
| |
| EP2773338B1 | Improving Recognition | NUTRICIA NV |
05 Nov, 2019
(Expiration: Oct, 2032)
|
SOCIT DES PRODUITS NESTL
| |
| EP3226827B2 | Aluminium-Free Antiperspirant/Deodorant Compositions And Method Of Preparing The Same | STOCKHOLMS ANALYTISKA LABORATORIUM |
29 Oct, 2019
|
HENKEL
(and 1 more)
| |
| EP2925350B1 | Enhancing Anti-Cancer Activity Of Immunomodulatory Fc Fusion Proteins | BRISTOL MYERS SQUIBB |
29 Oct, 2019
|
PLOUGMANN VINGTOFT
| |
| EP3109258B1 | Recombinant Rsv Antigens | GLAXOSMITHKLINE BIOLOGICALS SA |
23 Oct, 2019
(Expiration: Dec, 2028)
|
JANSSEN VACCINES & PREVENTION
(and 1 more)
| |
| EP2934698B1 | Trans-Resveratrol Or Trans-Resveratrol Derivative Composition | LORAL |
22 Oct, 2019
|
IPAZ
| |
| EP2731947B1 | Substituted Quinazolines, The Preparation Thereof And The Use Thereof In Pharmaceutical Compositions | BOEHRINGER INGELHEIM |
16 Oct, 2019
(Expiration: Jul, 2032)
|
BRCHER
| |
| EP2348832B1 | Preservative System For Emulsion-Based Therapeutic Topical Formulations | ARBOR PHARMACEUTICALS |
16 Oct, 2019
|
GENERICS UK
| |
| EP3140011B2 | Aqueous Cosmetic Powder Composition | KAO GERMANY |
16 Oct, 2019
|
HENKEL
| |
| EP2277597B1 | Reductive Colour Removal | HENKEL |
16 Oct, 2019
|
LORAL
| |
| EP3126381B2 | Claudin-6-Specific Immunoreceptors And T Cell Epitopes | BIONTECH CELL&GENE THERAPIES |
16 Oct, 2019
|
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP2988757B2 | Treatment Of Skin Injuries Associated With Auto-Immune And Inflammatory Diseases Using The Arsenic Compound As2O5 | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS |
15 Oct, 2019
|
MEDSENIC
| |
| EP2900236B2 | Treatment Of Wolfram Syndrome-Related Neurodegeneration | THE UNIVERSITY OF BIRMINGHAM |
15 Oct, 2019
|
NEUROFIX SL
| |
| EP2962690B1 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof | AMGEN EUROPE |
11 Oct, 2019
|
GENERICS UK
(and 14 more)
| |
| EP1617823B1 | A Composition Material For Transmucosal Delivery | NICACHET AB |
09 Oct, 2019
(Expiration: Jan, 2024)
|
KELTIE
| |
| EP3094631B1 | Pyrimidinyloxy Benzene Derivatives As Herbicides | FMC |
09 Oct, 2019
|
MAINSTAY
| |
| EP2099480B1 | Microorganisms Of Fractions Thereof Capable Of Activating Cellular Immunity Against Carbohydrates | TE BIOS |
09 Oct, 2019
|
PATENT BOUTIQUE
| |
| EP3271404B1 | Water-Soluble Esterified Cellulose Ethers | DOW |
09 Oct, 2019
|
SHIN ETSU CHEMICAL
| |
| EP3270971B1 | Water-Soluble Esterified Cellulose Ethers Having A Low Degree Of Neutralization | DOW |
09 Oct, 2019
|
SHIN ETSU CHEMICAL
| |
| EP3270970B1 | Gelling Esterified Cellulose Ethers | DOW |
09 Oct, 2019
|
SHIN ETSU CHEMICAL
| |
| EP2981275B1 | Lozenge For Treating A Sore Throat, Hoarseness, And Associated Dry Cough And For Treating Inflammatory Diseases Of The Oral Cavity And Of The Pharynx | SANOFI AVENTIS DEUTSCHLAND GMBH |
09 Oct, 2019
(Expiration: Mar, 2034)
|
STREHLKE
| |
| EP3270973B1 | Aqueous Solution Of An Esterified Cellulose Ether | DOW |
08 Oct, 2019
|
SHIN ETSU CHEMICAL
| |
| EP2464337B1 | Pharmaceutical Composition And Administrations Thereof | VERTEX PHARMACEUTICALS INCORPORATED |
07 Oct, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2299989B1 | Stabilized Transdermal Drug Delivery System | MYLAN |
02 Oct, 2019
|
AMW
| |
| EP2794014B1 | Product For Temporarily Shaping Keratin Fibers On The Basis Of A Combination Of Specific Film-Forming Polymers | HENKEL AG AND CO KGAA |
02 Oct, 2019
(Expiration: Nov, 2032)
|
LOREAL
| |
| EP3210591B1 | Compositions And Methods For Targeted Thermomodulation | SEBACIA |
02 Oct, 2019
|
SEBACIA
| |
| EP2676679B1 | Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions | WYETH |
02 Oct, 2019
|
SK BIOSCIENCE
(and 2 more)
| |
| EP2925282B1 | Mild Antibacterial Cleansing Compositions | UNILEVER |
01 Oct, 2019
|
BEIERSDORF
| |
| EP2535355B1 | Antibodies Against Cd38 For Treatment Of Multiple Myeloma | GENMAB AS |
01 Oct, 2019
(Expiration: Mar, 2026)
|
SECERNA
| |
| EP2368914B1 | Anti-5T4 Antibodies And Uses Thereof | WYETH LLC |
01 Oct, 2019
(Expiration: Mar, 2027)
|
SYNTHON BIOPHARMACEUTICALS
| |
| EP2922598B2 | Sensorily Attractive Hydrodispersion Having Waxes | BEIERSDORF |
30 Sep, 2019
|
HENKEL
| |
| EP2785374B2 | Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof | BOEHRINGER INGELHEIM ANIMAL HEALTH USA |
30 Sep, 2019
(Expiration: Nov, 2032)
|
INTERVET
| |
| EP2421841B1 | Improved Method Of Achieving And Maintaining A Specified Alkylene Oxide Production Parameter With A High Efficiency Catalyst | DOW TECHNOLOGY INVESTMENTS LLC |
26 Sep, 2019
(Expiration: Apr, 2030)
|
BASF
| |
| EP2827845B1 | Compositions Comprising A Delivery Agent And Preparation Thereof | NOVO NORDISK AS |
26 Sep, 2019
(Expiration: Mar, 2033)
|
CMS CAMERON MCKENNA NABARRO OLSWANG
(and 4 more)
| |
| EP2359869B1 | Adeno-Associated Virus (Aav) Serotype 8 Sequences, Vectors Containing Same And Uses Therefor | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
26 Sep, 2019
|
GRUND
| |
| EP3185962B1 | Multi-Tonal One Step Dyeing With Thickened Pre-Treatment Solution Ii | HENKEL |
26 Sep, 2019
|
KAO GERMANY
| |
| EP2888290B1 | Novel Esterified Cellulose Ethers Of High Molecular Weight And Homogeneity | DOW |
26 Sep, 2019
|
SHIN ETSU CHEMICAL
| |
| EP3140320B1 | Peptide Vaccine Comprising Mutant Ras Peptide And Chemotherapeutic Agent | TARGOVAX SOLUTIONS |
26 Sep, 2019
|
STRAWMAN
| |
| EP2598151B1 | Compositions For Treating Heartworm Infestation | CEVA SANTE ANIMALE SA |
25 Sep, 2019
(Expiration: Jul, 2031)
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP2958541B1 | Gel-Type Cosmetic Composition | LOREAL |
25 Sep, 2019
|
HENKEL
| |
| EP2640853B1 | Modulation Of Alpha Synuclein Expression | IONIS PHARMACEUTICALS |
25 Sep, 2019
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP3020730B1 | Anti-Il1Rap Antibodies And Their Use For Treating Human | CANTARGIA |
25 Sep, 2019
|
MAB DISCOVERY
| |
| EP2962686B1 | Dosage Form Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
24 Sep, 2019
(Expiration: Feb, 2026)
|
KRKA
(and 6 more)
| |
| EP3205338B1 | Method Of Producing Enteric Soft Capsule | FUJI CAPSULE |
19 Sep, 2019
|
CP KELCO APS
| |
| EP1477189B1 | Process For Production Of Pressure-Sensitive Adhesive Moldings Comprising Crosslinked Polymers As The Main Component | HISAMITSU PHARMACEUTICAL CO INC |
19 Sep, 2019
(Expiration: Jan, 2023)
|
LTS LOHMANN THERAPIE SYSTEME
| |
| EP2731626B1 | Photosensitizing Antibody-Fluorophore Conjugates | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES |
18 Sep, 2019
|
STRAWMAN
| |
| EP3206873B1 | Laminate Changing Device | LUYE SUPPLY |
12 Sep, 2019
|
STRAWMAN
| |
| EP2531218B1 | Immunoglobulin Preparation | CSL BEHRING |
11 Sep, 2019
|
UCB BIOPHARMA SPRL
| |
| EP3070090B1 | Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile | INCYTE HOLDINGS CORP |
06 Sep, 2019
(Expiration: Jun, 2028)
|
GENERICS UK
| |
| EP3250185B1 | Ophthalmic Suspension Composition | BAUSCH AND LOMB INC |
05 Sep, 2019
(Expiration: Jan, 2036)
|
EUROPEAN OPPOSITIONS
(and 2 more)
| |
| EP2874630B1 | Dosing Regimen For Janus Kinase (Jak) Inhibitors | ZOETIS SERVICES LLC |
05 Sep, 2019
(Expiration: Jul, 2033)
|
KRKA
| |
| EP2176357B1 | A Colouring Composition Comprising Starch Derivatives As A Hydrocolloid | CHR HANSEN NATURAL COLORS AS |
05 Sep, 2019
(Expiration: Jul, 2028)
|
SENSIENT COLORS EUROPE
(and 1 more)
| |
| EP2734175B1 | Use, As Antiperspirant, Of A Polyvalent Cation Salt Without Aluminium Halide Antiperspirant Or Compound Capable Of Reacting With Said Salt In Order To Produce An Antiperspirant Effect | LOREAL |
04 Sep, 2019
|
BEIERSDORF
| |
| EP3052131B1 | Methods For Treating Cancer In Patients With Elevated Levels Of Bim | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
04 Sep, 2019
|
MERCK PATENT
(and 1 more)
| |
| EP2658546B1 | Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health | ABBOTT LABORATORIES |
04 Sep, 2019
(Expiration: Dec, 2031)
|
SOCIT DES PRODUITS NESTL
| |
| EP3204045B1 | Pharmaceutical Formulations For The Oral Delivery Of Peptide Or Protein Drugs | CYPRUMED GMBH |
03 Sep, 2019
(Expiration: Oct, 2035)
|
SANOFI
| |
| EP3143995B1 | A Rapamycin Derivative For Treating Lung Cancer | NOVARTIS PHARMA |
03 Sep, 2019
(Expiration: Feb, 2022)
|
ZENTIVA KS
(and 6 more)
| |
| EP3017811B1 | Apixaban Formulations | BRISTOL MYERS SQUIBB IRELAND UNLIMITED |
30 Aug, 2019
|
HAMM&WITTKOPP PATENTANWLTE PARTMBB
(and 8 more)
| |
| EP3031466B1 | Purified Amphiphilic Peptide Compositions And Uses Thereof | 3D MATRIX INC |
28 Aug, 2019
(Expiration: Jul, 2025)
|
ARCH THERAPEUTICS
| |
| EP3082746B1 | Shaping Keratin Fibres Using An Amine Or A Diamine | THE PROCTER & GAMBLE |
28 Aug, 2019
|
LOREAL
| |
| EP2486806B1 | Stevia Composition | PURECIRCLE USA INC |
28 Aug, 2019
(Expiration: Aug, 2031)
|
SAGITTARIUS CONSULTANTS
| |
| EP2301516B1 | Aerosol Compositions With Stabilised Particulate Materials | BEIERSDORF |
28 Aug, 2019
|
UNILEVER
| |
| EP2968152B2 | Methods And Systems For Conditioning Of Particulate Crystalline Materials | PEARL THERAPEUTICS |
28 Aug, 2019
|
VECTURA
| |
| EP3119436B1 | Sheet-Like Structure For The Controlled Release Of Active Substances | CARL FREUDENBERG KG |
27 Aug, 2019
(Expiration: Mar, 2035)
|
MAHLE
| |
| EP3191084B2 | Solid Dosage Form Production | UNIVERSITY OF CENTRAL LANCASHIRE |
27 Aug, 2019
|
MERCK PATENT
| |
| EP2299984B1 | Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof | CELGENE |
27 Aug, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
| |
| EP3342411B1 | Rapamycin Derivative For Treating Pancreas Cancer | NOVARTIS PHARMA AG |
23 Aug, 2019
(Expiration: Feb, 2022)
|
ACCORD HEALTHCARE
(and 9 more)
| |
| EP2797570B1 | Antiperspirant Aerosol Preparations With Reduced Textile Staining | BEIERSDORF AG |
23 Aug, 2019
(Expiration: Dec, 2032)
|
THE PROCTER & GAMBLE
| |
| EP2988722B1 | Composition Comprising Henna And/Or Indigo, An Oil And A Saccharide, And Hair Dyeing Process Using The Same | LOREAL SA |
22 Aug, 2019
(Expiration: Apr, 2034)
|
COTY
| |
| EP2958544B1 | Soft Solid Oil-In-Water Emulsion Comprising A Mixture Of Nonionic Surfactants, A Water-Soluble Polysaccharide And A Wax Comprising At Least One Ester | LORAL |
21 Aug, 2019
|
BAYER BAYER CONSUMER CARE
(and 1 more)
| |
| EP3111957B1 | Magnesium Oxide Granules For Pharmaceutical Applications Or Food Additive Applications | KONOSHIMA CHEMICAL |
21 Aug, 2019
|
DEAD SEA BROMINE
| |
| EP2869813B1 | Syringe | NOVARTIS AG |
21 Aug, 2019
(Expiration: Jan, 2033)
|
DILG
(and 1 more)
| |
| EP2664328B2 | Omega3 Fatty Acid Compound Preparation | MOCHIDA PHARMACEUTICAL |
21 Aug, 2019
|
FH SERVICES
| |
| EP2970677B1 | Small Scale Microencapsulated Pigments And Uses Thereof | CHROMATIC TECHNOLOGIES INC |
21 Aug, 2019
(Expiration: Mar, 2034)
|
SOCIT BIC
| |
| EP2833866B1 | Soft Chewable Pharmaceutical Products | INTERVET |
21 Aug, 2019
|
VIRBAC
(and 1 more)
| |
| EP3167900B1 | Vaccine Against Streptococci | MERIAL LTD |
20 Aug, 2019
(Expiration: Mar, 2027)
|
AWA SWEDEN
| |
| EP3078667B1 | Formulation Of Boronic Acid Compounds | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES |
20 Aug, 2019
|
DR REDDYS LABORATORIES
(and 10 more)
| |
| EP2207507B1 | Once-A-Day Replacement Transdermal Administration Of Fentanyl | ALZA CORP |
20 Aug, 2019
(Expiration: Oct, 2028)
|
HEXAL
| |
| EP3027063B1 | Glyceride Composition | BUNGE LODERS CROKLAAN BV |
20 Aug, 2019
(Expiration: Jul, 2034)
|
NEDERLANDSCH OCTROOIBUREAU
(and 1 more)
| |
| EP2313087B2 | Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative | BOEHRINGER INGELHEIM |
20 Aug, 2019
(Expiration: Jun, 2029)
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
| |
| EP2282758B1 | Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related Disorders | BIOARCTIC |
16 Aug, 2019
|
JAMES POOLE
(and 2 more)
| |
| EP2482841B2 | Compositions And Methods For Enhancing Coagulation Factor Viii Function | THE CHILDRENS HOSPITAL OF PHILADELPHIA |
16 Aug, 2019
|
STRAWMAN
(and 2 more)
| |
| EP1846030B1 | Fixed Dosing Of Her Antibodies | GENENTECH INC |
15 Aug, 2019
(Expiration: Jun, 2025)
|
KNIG SZYNKA TILMANN VON RENESSE
(and 3 more)
| |
| EP3209381B1 | Compositions Comprising Bacterial Strains | 4D PHARMA RESEARCH LTD |
14 Aug, 2019
(Expiration: Nov, 2036)
|
BRADY
(and 1 more)
| |
| EP3071219B1 | Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor | TAKEDA PHARMACEUTICAL |
14 Aug, 2019
|
CSL INNOVATION
| |
| EP2981271B1 | Therapeutic Uses Of Empagliflozin | BOEHRINGER INGELHEIM |
14 Aug, 2019
(Expiration: Apr, 2034)
|
GENERICS UK
(and 7 more)
| |
| EP1793855B2 | Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease | PROTHENA BIOSCIENCES |
14 Aug, 2019
|
MATHYS & SQUIRE
| |
| EP2748192B2 | Novel Kif5B-Ret Fusion Molecules And Uses Thereof | FOUNDATION MEDICINE |
14 Aug, 2019
|
STRAWMAN
(and 1 more)
| |
| EP3102605B1 | Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer | MERCK SHARP AND DOHME LLC |
14 Aug, 2019
(Expiration: Feb, 2035)
|
WITHERS & ROGERS
(and 1 more)
| |
| EP3060303B1 | Mrna Therapy For Argininosuccinate Synthetase Deficiency | TRANSLATE BIO INC |
14 Aug, 2019
(Expiration: Oct, 2034)
|
WITHERS & ROGERS
| |
| EP2934160B1 | Low Viscosity, High Caloric Density Oral Nutritional Composition And Related Methods | ABBOTT LABORATORIES |
13 Aug, 2019
|
FRESENIUS KABI DEUTSCHLAND
(and 1 more)
| |
| EP2961486B2 | Multi-Tonal One Step Dyeing Ii | HENKEL |
13 Aug, 2019
|
KAO GERMANY
(and 1 more)
| |
| EP2298279B1 | Pharmaceutical Compositions For Inhalation | VECTURA LTD |
12 Aug, 2019
(Expiration: Nov, 2021)
|
GLAXO GROUP
| |
| EP2714000B2 | Composition Comprising An Alkoxysilane And A Modified Starch, And Cosmetic Use Thereof | LOREAL |
12 Aug, 2019
|
HENKEL
| |
| EP2824181B1 | Novel Fgfr3 Fusion Product | ASTELLAS PHARMA INC |
12 Aug, 2019
(Expiration: Mar, 2033)
|
JAMES POOLE
(and 1 more)
| |
| EP3033070B1 | Process For Treating Keratin Fibres Using An Aqueous-Alcoholic Composition Comprising An Organic Monoacid | LORAL |
09 Aug, 2019
|
KAO GERMANY
| |
| EP3141254B1 | Lactobacillus Rhamnosus Rht-3201 Conjugated To Polysaccharide Polymer Binder, And Use Thereof For Prevention Or Treatment Of Atopic Diseases | ILDONG PHARMACEUTICAL |
08 Aug, 2019
|
SOCIT DES PRODUITS NESTL
| |
| EP3045175B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
07 Aug, 2019
(Expiration: Sep, 2024)
|
GENERICS UK
| |
| EP3045176B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
07 Aug, 2019
(Expiration: Sep, 2024)
|
GENERICS UK
| |
| EP3042659B8 | Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione | CELGENE CORP |
07 Aug, 2019
(Expiration: Sep, 2024)
|
HAMM&WITTKOPP PATENTANWLTE PARTMBB
(and 4 more)
| |
| EP2956146B2 | Stem Cell Microparticles And Mirna | RENEURON |
07 Aug, 2019
|
PAJARO
| |
| EP1832179B1 | Carbohydrate Fraction Composition And Flat Glucose Response | NUTRICIA NV |
07 Aug, 2019
(Expiration: Dec, 2025)
|
SOCIT DES PRODUITS NESTL
| |
| EP2736487B1 | New (Trimethoxyphenylamino)Pyrimidinyl Formulations | RIGEL PHARMACEUTICALS |
07 Aug, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2673237B1 | Microporous Zirconium Silicate For The Treatment Of Hyperkalemia | ZS PHARMA |
06 Aug, 2019
|
GALENICUM HEALTH SLU
(and 2 more)
| |
| EP2879649B2 | Dyeing Composition Comprising At Least One Fatty Substance, At Least One Oxidizing Agent And At Least One Non-Ionic, Anionic And Amphoteric Surfactant | LOREAL |
06 Aug, 2019
|
HENKEL
| |
| EP3017827B1 | Pneumococcal Polysaccharide Conjugate Vaccine | GLAXOSMITHKLINE BIOLOGICALS |
06 Aug, 2019
(Expiration: Dec, 2026)
|
SK BIOSCIENCE
(and 2 more)
| |
| EP2850189B8 | Compositions And Methods For Modulating Gene Expression | GENERAL HOSPITAL CORP |
02 Aug, 2019
(Expiration: May, 2033)
|
ROCHE INNOVATION CENTER COPENHAGEN
| |
| EP2983697B1 | Treatment Of Diabetes Mellitus By Long Acting Formulations Of Insulins | SANOFI SA |
31 Jul, 2019
(Expiration: Apr, 2034)
|
COOKE
| |
| EP2694049B1 | Tapentadol For Preventing Chronification Of Pain | GRUENENTHAL GMBH |
31 Jul, 2019
(Expiration: Apr, 2032)
|
GENERICS UK
(and 1 more)
| |
| EP2964202B2 | Oral Formulations Of Deferasirox | NOVARTIS |
31 Jul, 2019
(Expiration: Mar, 2034)
|
INVOKAT SERVICES
(and 2 more)
| |
| EP2512425B1 | Cleansing Composition | KAO GERMANY GMBH |
31 Jul, 2019
(Expiration: Dec, 2030)
|
LOREAL
| |
| EP3160228B1 | Synergistic Antimicrobial Composition Of Zinc Pyrithione | JUBILANT INGREVIA |
31 Jul, 2019
|
THE PROCTER & GAMBLE
| |
| EP1565201B1 | Methods Of Administering Dalbavancin For Treatment Of Bacterial Infections | VICURON PHARMACEUTICALS |
30 Jul, 2019
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP3033079B1 | Methods For The Treatment Of Her2 Amplified Cancer | PHARMACYCLICS LLC |
30 Jul, 2019
(Expiration: Aug, 2034)
|
GENERICS UK
| |
| EP2877147B1 | Process | UNILEVER |
30 Jul, 2019
|
HENKEL
| |
| EP2072054B1 | Use Of A Ginkgo Biloba Leaf Extract | DR WILLMAR SCHWABE |
29 Jul, 2019
|
KRNZLE
(and 3 more)
| |
| EP2968241B1 | Materials And Methods For Improving Lung Function And For Prevention And/Or Treatment Of Radiation-Induced Lung Complications | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION |
29 Jul, 2019
|
NEDERLANDSCH OCTROOIBUREAU
| |
| EP1803443B1 | A Method For The Preparation Of A Nicotine-Containing Particulate Material With A Crystalline Cellulose (In Particular Mcc) | NICONOVUM |
26 Jul, 2019
|
PHILIP MORRIS PRODUCTS
(and 1 more)
| |
| EP1803444B1 | A Method For The Preparation Of A Nicotine-Containing Particulate Material With A Crystalline Cellulose (In Particular Mcc) | NICONOVUM |
25 Jul, 2019
|
PHILIP MORRIS PRODUCTS
(and 1 more)
| |
| EP2920248B1 | Surface-Modified Calcium Oxide | KALKFABRIK NETSTAL |
25 Jul, 2019
|
SCHAEFER KALK
| |
| EP2568967B2 | Pharmaceutical Compositions Comprising Hydromorphone And Naloxone | EURO CELTIQUE |
24 Jul, 2019
|
NEIDLEIN
(and 1 more)
| |
| EP2784084B2 | Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof | NOVARTIS PHARMA AG |
24 Jul, 2019
(Expiration: Jun, 2024)
|
NOVARTIS
(and 3 more)
| |
| EP3122878B1 | Mrna Therapy For The Treatment Of Ocular Diseases | TRANSLATE BIO |
24 Jul, 2019
|
PRFER & PARTNER MBB
| |
| EP2874647B1 | Method Of Diagnosis And Treatment | LA TROBE UNIVERSITY |
23 Jul, 2019
(Expiration: Jul, 2033)
|
GRUND
| |
| EP2750707B1 | Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna | GLAXOSMITHKLINE BIOLOGICALS SA |
23 Jul, 2019
(Expiration: Aug, 2032)
|
MLLER
(and 1 more)
| |
| EP3025705B8 | Stable Ivabradine Formulations | SANOFI ILAC SANAYI VE TICARET AS |
22 Jul, 2019
(Expiration: Nov, 2034)
|
HGF
| |
| EP3229799B1 | Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof | CRYSTAL PHARMATECH |
17 Jul, 2019
|
D YOUNG
| |
| EP3196301B1 | Methods And Compositions For The Treatment Of Monogenic Diseases | SANGAMO THERAPEUTICS INC |
17 Jul, 2019
(Expiration: Mar, 2033)
|
MATHYS & SQUIRE
(and 2 more)
| |
| EP2081669B8 | Granules, Tablets And Granulation | ATACAMA LABS |
17 Jul, 2019
|
OMYA
| |
| EP2852370B1 | Radiance Compositions And Methods Of Use | JOHNSON AND JOHNSON CONSUMER INC |
16 Jul, 2019
(Expiration: May, 2032)
|
HENKEL
| |
| EP2724728B1 | Complexes Of Il-15 And Il-15R Alpha And Uses Thereof | NOVARTIS AG |
16 Jul, 2019
(Expiration: Jun, 2028)
|
HGF
| |
| EP3065731B1 | Methods And Compositions For Improving Kidney Function | HILLS PET NUTRITION INC |
16 Jul, 2019
(Expiration: Nov, 2033)
|
IAMS EUROPE
| |
| EP2345400B1 | Lightening Composition Having Reduced Hair Damage | HENKEL AG AND CO KGAA |
16 Jul, 2019
(Expiration: Nov, 2030)
|
KAO GERMANY
| |
| EP2753187B1 | Method For Preventing And/Or Treating Insulin Resistance | CAELUS PHARMACEUTICALS |
15 Jul, 2019
|
STRAWMAN
| |
| EP1848422B1 | Method For Decreasing Cartilage Damage In Dogs | HILLS PET NUTRITION INC |
11 Jul, 2019
(Expiration: Feb, 2026)
|
MARS
(and 1 more)
| |
| EP2380552B1 | Emulsion Composition, And Food And Cosmetic Each Containing The Emulsion Composition | FUJIFILM |
10 Jul, 2019
|
DSM NUTRITIONAL PRODUCTS
| |
| EP2968243B1 | Nutritional Supplement Targeting Meibomian Glands | PRN PHYSICIAN RECOMMENDED NUTRICEUTICALS |
10 Jul, 2019
|
GEORGIOU
| |
| EP2882454B1 | Combination Therapy For The Treatment Of Glioblastoma | F HOFFMANN LA ROCHE AG |
10 Jul, 2019
(Expiration: Aug, 2033)
|
NEUEFEIND
(and 2 more)
| |
| EP2723195B1 | Method For Reducing The Occurrence Of Infection In Young Children | NUTRICIA |
10 Jul, 2019
|
SOCIT DES PRODUITS NESTL
(and 1 more)
| |
| EP1784222B1 | Nutritional Composition Comprising Indigestible Oligosaccharides | NUTRICIA NV |
10 Jul, 2019
(Expiration: Aug, 2025)
|
SOCIT DES PRODUITS NESTL
| |
| EP1747001B1 | Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens | BAYER |
10 Jul, 2019
|
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 1 more)
| |
| EP2768964B1 | Recombinant Non-Pathogenic Marek'S Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus And Newcastle Disease Virus Antigens | INTERVET |
09 Jul, 2019
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP2586319B1 | Composition Comprising Flavouring Substances And Organic Acids And Use Thereof | VETAGRO |
09 Jul, 2019
|
DSM NUTRITIONAL PRODUCTS
| |
| EP2884973B1 | Buffer Substance For The Treatment Of Wounds | PAUL HARTMANN |
09 Jul, 2019
|
KCI LICENSING
| |
| EP2515992B1 | Swallowable Drug Delivery Device And Methods Of Drug Delivery | RANI THERAPEUTICS |
09 Jul, 2019
|
NOVO NORDISK
| |
| EP2269603B1 | Treatment Of Solid Tumours With Rapamycin Derivatives | NOVARTIS PHARMA GMBH |
08 Jul, 2019
(Expiration: Feb, 2022)
|
ZENTIVA FRANCE
(and 8 more)
| |
| EP2036546B1 | Psychostimulant Containing Pharmaceutical Composition | PEJO ISERLOHN HEILMITTEL UND DIT & COKG |
05 Jul, 2019
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP3214091B1 | Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer | UNIVERSITY OF PENNSYLVANIA PENN |
03 Jul, 2019
(Expiration: Dec, 2031)
|
CABINET PLASSERAUD
(and 3 more)
| |
| EP3009143B1 | Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease | NEURODYN LIFE SCIENCES INC |
03 Jul, 2019
(Expiration: Jan, 2029)
|
CMS CAMERON MCKENNA NABARRO OLSWANG
(and 1 more)
| |
| EP2805625B2 | Nutritional Composition With Probiotics | NUTRICIA |
03 Jul, 2019
|
HOFFMANN EITLE
| |
| EP2793831B2 | Cosmetic Composition Comprising An Anionic Surfactant, A Solid Fatty Alcohol And A Solid Fatty Ester, And Cosmetic Treatment Process | LORAL |
02 Jul, 2019
|
BEIERSDORF
(and 2 more)
| |
| EP2297207B1 | Use Of Anti-Factors Xi Antibodies For Prevention Of Thrombus Formation | PROTHIX |
02 Jul, 2019
|
MATHYS & SQUIRE
| |
| EP3351246B8 | Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis | NOVARTIS PHARMA AG |
01 Jul, 2019
(Expiration: Feb, 2022)
|
BIOGARAN
(and 9 more)
| |
| EP2156751B8 | Novel Sweetener Having Sugar-Like Taste And Production Method And Use Of The Same | MATSUTANI CHEMICAL INDUSTRY |
01 Jul, 2019
|
HANNA MOORE & CURLEY
| |
| EP3184526B1 | Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor | INCYTE |
28 Jun, 2019
|
CONCERT PHARMACEUTICALS
| |
| EP3087852B1 | Oral Pouched Product Having A Rectangular Shape | SWEDISH MATCH NORTH EUROPE |
27 Jun, 2019
|
BRITISH AMERICAN TOBACCO INVESTMENTS
(and 2 more)
| |
| EP3086782B1 | Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus | DR FALK PHARMA |
26 Jun, 2019
|
ADARE
| |
| EP2322153B1 | Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis | FIBROGEN INC |
26 Jun, 2019
(Expiration: Jun, 2024)
|
GLAXOSMITHKLINE UK
(and 3 more)
| |
| EP3025719B1 | Combination Immunotherapy Of Antigen-Recognizing Receptors And Hematopoietic Cells For The Treatment Of Diseases | MILTENYI BIOTEC GMBH |
26 Jun, 2019
(Expiration: Nov, 2035)
|
HOFFMANN EITLE
| |
| EP2285410B1 | Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
26 Jun, 2019
(Expiration: Apr, 2029)
|
ISARPATENT PATENT UND RECHTSANWLTE BEHNISCH BARTH CHARLES HASSA PECKMANN UND PARTNER MBB
(and 3 more)
| |
| EP2723304B1 | Cleaning Composition Comprising A Gelling Agent And A Foaming Surfactant | ESSITY OPERATIONS FRANCE |
25 Jun, 2019
|
HENKEL
| |
| EP2882687B1 | Method For Producing Stabilized Amorphous Calcium Carbonate | AMORPHICAL |
24 Jun, 2019
|
SCHAEFER KALK
| |
| EP2696861B1 | Combination Of Epa, Dpa And/Or Dha With A Chemotherapeutic Agent | NUTRICIA NV |
21 Jun, 2019
(Expiration: Apr, 2032)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP3060195B1 | Cosmetic Composition Based On Hyaluronic Acid, Method Of Preparation And Use Thereof | CONTIPRO AS |
21 Jun, 2019
(Expiration: Oct, 2034)
|
STELLENBOSCH NANOFIBER
| |
| EP3027186B1 | Composition Comprising Hyaluronic Acid And Mepivacaine | TEOXANE |
21 Jun, 2019
|
VIVACY
(and 2 more)
| |
| EP2785308B2 | Novel Hair Cleansing Composition | LORAL |
20 Jun, 2019
|
BEIERSDORF
| |
| EP2576578B1 | Polymorphs Of 2'-O-Fucosyllactose And Producing Thereof | GLYCOM AS |
19 Jun, 2019
(Expiration: Jun, 2031)
|
BASF
| |
| EP3212667B1 | Pharmaceutical Anti-Tnf-Alpha Antibody Formulation | RICHTER GEDEON NYRT |
19 Jun, 2019
|
BIOGEN
(and 1 more)
| |
| EP3058958B1 | Anidulafungin Composition | SELECTCHEMIE AG |
19 Jun, 2019
(Expiration: Feb, 2036)
|
COOKE
| |
| EP2744477B1 | Methods Of Enhancing Skin Hydration And Improving Non-Diseased Skin | THE PROCTER & GAMBLE |
19 Jun, 2019
|
HENKEL
| |
| EP2282978B1 | Lithium Silicate Glass Ceramic And Method For Fabrication Of Dental Appliances | JAMES R GLIDEWELL DENTAL CERAMICS |
19 Jun, 2019
|
IVOCLAR VIVADENT
| |
| EP2794017B1 | Substance For Dyeing Keratin Fibers, Containing Cationic Anthraquinone Dyes And Fatty Acid Triglycerides | HENKEL |
19 Jun, 2019
|
LOREAL
| |
| EP3105317B1 | Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells | CELLECTIS |
19 Jun, 2019
|
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
| |
| EP3305302B1 | Compositions And Methods For Modulation Of Smn2 Splicing In A Subject | BIOGEN MA |
19 Jun, 2019
|
TAYLOR WESSING
| |
| EP2608784B1 | Treatment Of Hypertension And/Or Prevention Or Treatment Of Heart Failure In A Mammal Receiving Anti-Coagulant Therapy | NOVARTIS AG |
18 Jun, 2019
(Expiration: Aug, 2031)
|
GENERICS UK
(and 2 more)
| |
| EP2896628B1 | Process For Efficient Purification Of Neutral Human Milk Oligosaccharides (Hmos) From Microbial Fermentation | CHR HANSEN HMO |
18 Jun, 2019
|
GREAVES BREWSTER
(and 4 more)
| |
| EP2776066B1 | Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And Aging | UNIVERSITE LAVAL |
18 Jun, 2019
(Expiration: Nov, 2032)
|
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
| |
| EP3238749B1 | Tissue Plug | D MATRIX |
18 Jun, 2019
|
POTTER CLARKSON
| |
| EP2916856B2 | Uses Of Bremelanotide In Therapy For Female Sexual Dysfunction | PALATIN |
18 Jun, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2611422B1 | Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD |
14 Jun, 2019
(Expiration: Aug, 2031)
|
TEVA UK
(and 2 more)
| |
| EP3294270B1 | Pharmaceutical Composition Containing Rifaximin Alpha&Delta | SANDOZ AG |
12 Jun, 2019
(Expiration: Mar, 2037)
|
ALFASIGMA
(and 1 more)
| |
| EP2958916B1 | Solid Forms Of A Selective Cdk4/6 Inhibitor | PFIZER INC |
12 Jun, 2019
(Expiration: Feb, 2034)
|
GENERICS UK
(and 2 more)
| |
| EP2647707B1 | Cytotoxicity-Inducing Therapeutic Agent | CHUGAI PHARMACEUTICAL CO LTD |
12 Jun, 2019
(Expiration: Nov, 2031)
|
GENMAB
(and 4 more)
| |
| EP2867245B1 | Purification Of Iduronate-2-Sulfatase | TAKEDA PHARMACEUTICAL |
12 Jun, 2019
|
HGF
| |
| EP1771192B1 | Use Of Aspartate For Regulating Glucose Levels In Blood | NUTRICIA NV |
11 Jun, 2019
(Expiration: Jul, 2025)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP3166641B1 | A Process For The Preparation Of Formulations For Inhalation | ARVEN ILAC SANAYI VE TICARET |
11 Jun, 2019
|
VECTURA
| |
| EP2359800B1 | Composition For Cosmetic Treatment Of Keratin Fibres Comprising Volatile Linear Alkanes, C8-30 Fatty Alcohols And Mono- Or Polyglycosides | LOREAL SA |
07 Jun, 2019
(Expiration: Dec, 2030)
|
HENKEL
| |
| EP2806851B2 | Composition Comprising At Least One Specific Alkoxysilane Polymer | LOREAL |
05 Jun, 2019
|
HENKEL
| |
| EP2903458B1 | Methods For Enhancing The Effect Of Egcg On Mitigating Skeletal Muscle Loss | ABBOTT LABORATORIES |
05 Jun, 2019
|
NUTRICIA
| |
| EP3019153B1 | Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation | CHIESI FARMACEUTICI |
05 Jun, 2019
|
TEVA UK
| |
| EP3016654B1 | Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative Disorders | BRUSCHETTINI |
04 Jun, 2019
|
AMMELBURG
| |
| EP2914248B2 | Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases | VERTEX PHARMACEUTICALS INCORPORATED |
04 Jun, 2019
|
GENERICS UK
| |
| EP2598118B1 | Preservative Free Bimatoprost And Timolol Solutions | ALLERGAN |
04 Jun, 2019
|
HGF
(and 5 more)
| |
| EP2598119B1 | Preservative Free Brimonidine And Timolol Solutions | ALLERGAN INC |
04 Jun, 2019
(Expiration: Jul, 2031)
|
INSTONE
(and 1 more)
| |
| EP2922818B1 | Hydrophilic Linkers And Their Uses For Conjugation Of Drugs To Cell Binding Molecules | HANGZHOU DAC BIOTECH |
03 Jun, 2019
|
MASCHIO & SOAMES
(and 1 more)
| |
| EP2451300B2 | Heat Resistant Probiotic Compositions And Healthy Food Comprising Them | DEGAMA PROBIOTICS |
31 May, 2019
|
CHR HANSEN
| |
| EP2877146B1 | Process | UNILEVER |
31 May, 2019
|
HENKEL
| |
| EP2877143B1 | Process | UNILEVER |
31 May, 2019
|
HENKEL
| |
| EP3076997B1 | Swine Vaccine Against Prrs And Lawsonia Intracellularis | INTERVET |
29 May, 2019
|
BOEHRINGER INGELHEIM VETMEDICA
| |
| EP3166690B2 | Improved Decolorization Of Dyed Keratin Fibers | HENKEL |
29 May, 2019
|
LOREAL
| |
| EP2976359B2 | Methods For Treating Osteogenesis Imperfecta | GENZYME |
29 May, 2019
|
SAGITTARIUS CONSULTANTS
| |
| EP2609812B1 | Liquid Nucleotides/Nucleosides-Containing Product | NUTRICIA NV |
29 May, 2019
(Expiration: Mar, 2028)
|
SOCIT DES PRODUITS NESTL
| |
| EP2968351B1 | Opioid Receptor Modulator Dosage Formulations | ALLERGAN UNLIMITED |
28 May, 2019
|
SANDOZ
| |
| EP2566954B2 | Immunotherapy Using Redirected Allogeneic Cells | YEDA RESEARCH |
27 May, 2019
|
GRUND
| |
| EP2952191B1 | Sublingual Apomorphine | SUNOVION PHARMACEUTICALS |
22 May, 2019
|
D YOUNG
| |
| EP2872488B1 | Crystalline Forms Of A Prolyl Hydroxylase Inhibitor | FIBROGEN |
22 May, 2019
|
SANDOZ
(and 2 more)
| |
| EP3021820B1 | Antiperspirant Spray Devices And Compositions | PROCTER AND GAMBLE CO |
21 May, 2019
(Expiration: Jul, 2034)
|
BEIERSDORF
| |
| EP3093004B2 | Sun Protectant Free Of Octocrylene With Minimal Stickyness | BEIERSDORF |
21 May, 2019
|
EMIL KIESSLING
| |
| EP2739153B1 | Treatment Of Breast Cancer | MEDIVATION PROSTATE THERAPEUTICS |
21 May, 2019
|
GENERICS UK
| |
| EP2597968B1 | Process For Modifying The Properties Of Citrus Fiber | CARGILL INCORPORATED |
21 May, 2019
|
HERBSTREITH & FOX PEKTIN FABRIKEN
(and 1 more)
| |
| EP2688561B1 | Transdermal Compositions Comprising An Active Agent Layer And An Active Agent Conversion Layer | TEIKOKU PHARMA USA INC |
21 May, 2019
(Expiration: Mar, 2032)
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
| |
| EP3127542B1 | Antiviral Therapy | VIIV HEALTHCARE |
20 May, 2019
|
COOKE
(and 3 more)
| |
| EP2797573B1 | Method Of Treating Artificially Coloured Hair | KAO GERMANY |
20 May, 2019
|
HENKEL
| |
| EP3019146B1 | Long-Wear Cosmetic Composition | LOREAL SA |
17 May, 2019
(Expiration: Jul, 2034)
|
HENKEL
| |
| EP3056187B2 | Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T4 | ALTERGON |
17 May, 2019
|
UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES
| |
| EP2827885B1 | Compositions Of Glp-1 Peptides And Preparation Thereof | NOVO NORDISK |
15 May, 2019
(Expiration: Mar, 2033)
|
GENERICS UK
(and 3 more)
| |
| EP2991671B1 | Oral Dosing Of Glp-1 Compounds | NOVO NORDISK |
15 May, 2019
(Expiration: May, 2034)
|
GENERICS UK
(and 5 more)
| |
| EP2477645B1 | Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency | APTALIS PHARMA |
15 May, 2019
|
MATHYS & SQUIRE
| |
| EP2793877B2 | Chewing Gum Products Containing [(2-Isopropyl-5-Methyl-Cyclohexanecarbonyl)-Amino]-Acetic Acid Isopropyl Ester | WM WRIGLEY JR |
14 May, 2019
|
AXALBION
| |
| EP2854790B1 | Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media | ARES TRADING SA |
14 May, 2019
(Expiration: May, 2033)
|
FERRING
| |
| EP2864479B1 | Modulation Of Ube3A-Ats Expression | IONIS PHARMACEUTICALS |
14 May, 2019
|
FHOFFMANN LA ROCHE
| |
| EP2509566B2 | Process For Permanent Shaping Of Human Hair | KAO GERMANY |
13 May, 2019
|
HENKEL
| |
| EP2977372B1 | Polymorphs Of Febuxostat | SANDOZ AG |
10 May, 2019
(Expiration: Jun, 2031)
|
ALFRED E TIEFENBACHER
| |
| EP2964336B1 | Colour Changing Composition In Emulsion Form Comprising A Partially Neutralized, Crosslinked Acrylic Homopolymer Or Copolymer | LOREAL |
08 May, 2019
|
BEIERSDORF
| |
| EP1925282B1 | Low Density Cosmetic Formulations, Cosmetic Products Containing The Same And Methods Of Cosmetic Treatment Of Hair, And/Or Skin Using The Same | LOREAL SA |
08 May, 2019
(Expiration: Nov, 2027)
|
HENKEL
| |
| EP2861304B1 | Cosmetic Compositions Comprising Hyaluronan Biosynthesis Promoting Agents | SYMRISE |
08 May, 2019
|
MAYR KOTSCH PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP2598121B1 | A Method Of Controlling The Release Of An Active Ingredient From A Dosage Form | DOW GLOBAL TECHNOLOGIES LLC |
08 May, 2019
(Expiration: Jun, 2031)
|
TYLOSE & COKG
| |
| EP2797576B1 | Hair Dyeing Composition | KAO GERMANY GMBH |
07 May, 2019
(Expiration: Dec, 2032)
|
HENKEL
| |
| EP2837407B1 | Octocrylene-Free, Odour-Stable Sun Protection Agent | BEIERSDORF AG |
07 May, 2019
(Expiration: Jun, 2034)
|
LOREAL
(and 2 more)
| |
| EP2863762B1 | Method To Convert Insects Or Worms Into Nutrient Streams And Compositions Obtained Thereby | BUHLER (CHANGZHOU) INSECT TECHNOLOGIES COLTD |
07 May, 2019
(Expiration: Jun, 2033)
|
NEXTPROTEIN
(and 2 more)
| |
| EP2902029B1 | Ret Inhibitor | CHUGAI SEIYAKU KABUSHIKI KAISHA |
03 May, 2019
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP3103498B2 | Spray Dispenser For Nasal Drugs | AP PHARMA SYSTEMS ATOMIZADORES E DISPENSADORES LTDA |
02 May, 2019
|
APTAR RADOLFZELL
| |
| EP1844763B2 | Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, And Percutaneously Absorbable Preparation Holding Equipment | BIOSERENTACH |
02 May, 2019
|
COSMED PHARMACEUTICAL
(and 1 more)
| |
| EP2381923B2 | Safe Desmopressin Administration | ACERUS PHARMACEUTICALS USA |
01 May, 2019
|
FERRING
| |
| EP2498759B1 | Immediate Release Tablet Formulations | ASTRAZENECA UK LTD |
30 Apr, 2019
(Expiration: Nov, 2030)
|
GENERICS UK
(and 3 more)
| |
| EP3108872B2 | Hair Cosmetic | KAO |
30 Apr, 2019
|
HENKEL
| |
| EP3049157B2 | Hair Compositions Comprising Low Viscosity Silicone Polymers | THE PROCTER & GAMBLE |
30 Apr, 2019
|
HENKEL
| |
| EP3066119B1 | New Method To Concentrate Von Willebrand Factor Or Complexes Thereof | CSL |
30 Apr, 2019
|
HOFFMANN EITLE
| |
| EP2803366B1 | Compositions For Treating Or Preventing Oxalate-Related Disease | OXTHERA INTELLECTUAL PROPERTY AB |
30 Apr, 2019
(Expiration: Jun, 2025)
|
POHLMAN
| |
| EP2683395B1 | Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders | ASSISTANCE PUBLIQUE HPITAUX DE PARIS |
30 Apr, 2019
|
STRAWMAN
| |
| EP2994125B1 | Efficacious Treatment Of Nsclc And Predictive Clinical Marker Of The Responsiveness Of A Tumour To A Treatment | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
30 Apr, 2019
(Expiration: May, 2034)
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 3 more)
| |
| EP2818156B1 | Perfumed Cosmetic Preparation | BEIERSDORF AG |
29 Apr, 2019
(Expiration: Mar, 2029)
|
BASF
(and 1 more)
| |
| EP3298040B1 | Treatment Of Fibrosis | SINGAPORE HEALTH SERVICES PTE |
29 Apr, 2019
|
BAYER
| |
| EP3112376B1 | Bifunctional Polypeptides | IMMUNOCORE LTD |
29 Apr, 2019
(Expiration: May, 2030)
|
STORZ
| |
| EP2830622B1 | A Nicotine Oral Delivery Product Containing A Powder Enclosed In A Water Insoluble Pouch, Wherein Said Powder Comprises Nicotine And A Chewing Gum Composition | FNYZ |
29 Apr, 2019
|
SWEDISH MATCH NORTH EUROPE
| |
| EP3121171B1 | Crystalline Forms Of 5-Chloro-N2-(2-Isopropoxy-5-Methyl-4-Piperidin-4-Yl-Phenyl)-N4[2-(Propane-2-Sulfonyl)-Phenyl]-Pyrimidine-2,4-Diamine | NOVARTIS |
25 Apr, 2019
(Expiration: Dec, 2031)
|
GENERICS UK
(and 1 more)
| |
| EP2498758B1 | Bilayer Tablet Formulations | ASTRAZENECA |
25 Apr, 2019
(Expiration: Nov, 2030)
|
HOEFER & PARTNER PATENTANWLTE MBB
| |
| EP2570109B2 | Cosmetic Sun Protection Spray | BEIERSDORF |
24 Apr, 2019
|
BASF
(and 1 more)
| |
| EP3082963B1 | Styling Spray Having A Volume Effect | HENKEL |
24 Apr, 2019
|
BEIERSDORF
| |
| EP2477638B1 | Probiotic Stabilization | MJN US HOLDINGS LLC |
24 Apr, 2019
(Expiration: Sep, 2030)
|
CHR HANSEN NATURAL COLORS
(and 1 more)
| |
| EP3016527B1 | Treatment Of Obesity, The Metabolic Syndrome, Type 2 Diabetes, Cardiovascular Diseases, Dementia, Alzheimer'S Disease And Inflammatory Bowel Disease By Using At Least One Bacterial Strain From Prevotella | PROPREV |
24 Apr, 2019
|
DUPONT NUTRITION BIOSCIENCES APS
| |
| EP2854802B2 | Oil/Water-Emulsion-Type Topical Compositions Containing A Retinoid | GALDERMA RESEARCH |
24 Apr, 2019
|
GENERICS UK
| |
| EP2950774B1 | Dye Composition Using At Least One Coupler Of Meta-Phenylenediamine Type Substituted In Position 4 In A Medium Comprising A Fatty Substance, Processes And Device | LOREAL |
24 Apr, 2019
|
HENKEL
(and 1 more)
| |
| EP2931301B2 | Process For Purifying Insulin And Analogues Thereof | MERCK SHARP & DOHME |
24 Apr, 2019
|
HERZOG
| |
| EP3054926B1 | Hiv Treatment Formulation Of Atazanavir And Cobicistat | BRISTOL MYERS SQUIBB IRELAND UNLIMITED |
24 Apr, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2819701B2 | Immunotherapeutic Molecules And Uses | THE UNIVERSITY OF BIRMINGHAM |
23 Apr, 2019
|
FHOFFMANN LA ROCHE
| |
| EP2931741B1 | Porcine Parvovirus 5A, Methods Of Use And Vaccine | BOEHRINGER INGELHEIM VETMEDICA INC |
23 Apr, 2019
(Expiration: Jan, 2034)
|
INTERVET
| |
| EP2757902B1 | Interomone Compositions And Their Use To Modify Behavior In Different Vertebrate Species | SERGEANTS PET CARE PRODUCTS |
18 Apr, 2019
|
CEVA SANTE ANIMALE
| |
| EP2138154B1 | Hair Rinse With Amphotenside And Special Storage Life | BEIERSDORF |
18 Apr, 2019
|
HENKEL
| |
| EP2996670B1 | Transparent Bleaching Compositions With Proteins And/Or Silicone Oils | HENKEL |
18 Apr, 2019
|
LORAL
(and 1 more)
| |
| EP3076928B1 | Composition For Oxidative Colouring Of Hair, Comprising Specific Combinations Of Developers And Couplers | HENKEL |
18 Apr, 2019
|
LORAL
| |
| EP3076940B1 | Agent For The Oxidative Dyeing Of Hair, Containing Specific Combinations Of Developers And Couplers | HENKEL |
18 Apr, 2019
|
LOREAL
| |
| EP2535053B1 | Mitochondrial Function Improver | KAO |
18 Apr, 2019
|
NUTRICIA
| |
| EP2903636B1 | Immunogenic Compositions | GLAXOSMITHKLINE BIOLOGICALS SA |
18 Apr, 2019
(Expiration: Oct, 2033)
|
PFIZER
| |
| EP2954892B1 | Solid Compositions | ABBVIE IRELAND ULC |
17 Apr, 2019
(Expiration: Jun, 2031)
|
AECHTER
| |
| EP2766014B1 | Methods Of Treating Pediatric Patients Using Dexmedetomidine | HOSPIRA INC |
16 Apr, 2019
(Expiration: Sep, 2032)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP2658510B1 | Bleaching Composition Comprising A Polyhydroxy Carboxylic Acid | KAO GERMANY |
16 Apr, 2019
|
HENKEL
| |
| EP3199172B1 | Dosing Regimen For Multiple Sclerosis | YEDA RESEARCH |
11 Apr, 2019
|
G L PHARMA
(and 4 more)
| |
| EP2421541B1 | Novel Use | CLASADO INC |
11 Apr, 2019
(Expiration: Apr, 2030)
|
NUTRICIA
| |
| EP2345425B1 | Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs | LFB SA |
11 Apr, 2019
(Expiration: Dec, 2026)
|
OCTAPHARMA
(and 1 more)
| |
| EP2504353B2 | Lipopeptide Compositions And Related Methods | CUBIST PHARMACEUTICALS |
11 Apr, 2019
|
PAJARO
(and 1 more)
| |
| EP2368145B1 | Ophthalmic Devices For Delivery Of Hydrophobic Comfort Agents | ALCON |
10 Apr, 2019
|
COOPERVISION
| |
| EP2806855B1 | Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation | CHIESI FARMACEUTICI |
10 Apr, 2019
|
ZBM PATENTS
| |
| EP2833910B1 | Pcv/Mycoplasma Hyopneumoniae Combination Vaccine | ZOETIS SERVICES |
04 Apr, 2019
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP3401400B1 | Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
04 Apr, 2019
|
DF MP DRRIES FRANK MOLNIA & POHLMAN
(and 3 more)
| |
| EP2500014B1 | Slow Release Pharmaceutical Composition Made Of Microparticles | DEBIOPHARM |
04 Apr, 2019
|
GENERICS UK
| |
| EP3220883B1 | Composition Comprising Salt Of Acyl Glutamate As Primary Surfactant Or Primary Anionic Surfactant | UNILEVER |
04 Apr, 2019
|
THE PROCTER & GAMBLE
| |
| EP2298301B2 | Medicaments For Increasing Endogenous Erythropoietin (Epo) | FIBROGEN |
03 Apr, 2019
|
AKEBIA THERAPEUTICS
| |
| EP2289531B1 | Medicaments For Increasing Endogenous Erythropoietine (Epo) | FIBROGEN |
03 Apr, 2019
|
AKEBIA THERAPEUTICS
(and 1 more)
| |
| EP2991615B2 | Hair Care Shampoo | HENKEL |
03 Apr, 2019
|
BEIERSDORF
| |
| EP2026880B1 | Pharmaceutical And Cosmetic Use Of Silica | BLAA LONID HF |
03 Apr, 2019
|
BEIERSDORF
| |
| EP2992897B1 | Immunogenic Compositions Comprising Lawsonia Intercellularis | BOEHRINGER INGELHEIM VETMEDICA INC |
02 Apr, 2019
(Expiration: Mar, 2026)
|
INTERVET
(and 1 more)
| |
| EP2025318B1 | Two-Phase Composition For Conditioning Hair | KAO GERMANY GMBH |
01 Apr, 2019
(Expiration: Aug, 2028)
|
HENKEL
| |
| EP2630962B1 | Low Frequency Glatiramer Acetate Therapy | YEDA RESEARCH |
27 Mar, 2019
|
ALVOGEN IPCO
(and 4 more)
| |
| EP2496246B1 | Composition, Method, And Kit For Alpha-1 Proteinase Inhibitor | GRIFOLS THERAPEUTICS LLC |
27 Mar, 2019
(Expiration: Nov, 2030)
|
EUROPEAN OPPOSITIONS
| |
| EP2558092B1 | Combination Comprising A Cyclin Dependent Kinase 4 Or Cyclin Dependent Kinase (Cdk4/6) Inhibitor And An Mtor Inhibitor For Treating Cancer | NOVARTIS AG |
27 Mar, 2019
(Expiration: Apr, 2031)
|
GENERICS UK
| |
| EP2854803B2 | Topical Compositions In The Form Of A Gel Containing A Particular Solubilised Retinoid | GALDERMA RESEARCH |
26 Mar, 2019
|
GENERICS UK
| |
| EP3021833B2 | Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug | HEXAL |
26 Mar, 2019
|
MURPHY
| |
| EP3148510B1 | Liquid Pharmaceutical Composition | FRESENIUS KABI DEUTSCHLAND GMBH |
26 Mar, 2019
(Expiration: May, 2035)
|
SAMSUNG BIOEPIS UK
(and 1 more)
| |
| EP2234612B1 | Composition For Stimulating Natural Killer Cell Activity | NUTRICIA NV |
25 Mar, 2019
(Expiration: Jan, 2029)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP2497461B2 | Paediatric Solutions Comprising A Beta-Blocker | PIERRE FABRE DERMATOLOGIE |
20 Mar, 2019
|
AECHTER
| |
| EP2723758B1 | Angiopoietin-Like 3 (Angptl3) Irna Compostions And Methods Of Use Thereof | ALNYLAM PHARMACEUTICALS |
19 Mar, 2019
|
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
| |
| EP2964675B1 | Engager Cells For Immunotherapy | BAYLOR COLLEGE OF MEDICINE |
19 Mar, 2019
(Expiration: Mar, 2034)
|
SCHLICH
| |
| EP3049061B1 | Composition Comprising An Organic Liquid Diluent And A Specific Hydroxyalkyl Methylcellulose | DOW |
19 Mar, 2019
|
SHIN ETSU CHEMICAL
| |
| EP3216807B2 | Coating Composition Containing Methyl Cellulose, Method For Producing The Same, And Solid Preparation | SHIN ETSU CHEMICAL |
18 Mar, 2019
|
DUPONT NUTRITION BIOSCIENCES APS
| |
| EP3093007B1 | Octocrylene-Free Sunscreen Comprising Diethylamino Hydroxybenzoyl Hexyl Benzoate | BEIERSDORF |
15 Mar, 2019
|
BASF
(and 2 more)
| |
| EP2618801B2 | Cosmetic Composition Comprising At Least One Hygroscopic Salt, At Least One Aromatic Polyol Ether And At Least One Diol, And Cosmetic Treatment Process | LORAL |
13 Mar, 2019
|
HENKEL
| |
| EP2139515B2 | Attenuated Viruses Useful For Vaccines | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK |
13 Mar, 2019
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
| |
| EP2774481B1 | Antimicrobial Compositions | SYMRISE |
13 Mar, 2019
|
SCHLKE & MAYR
| |
| EP2307457B2 | Stable And Soluble Antibodies Inhibiting Tnf | NOVARTIS AG |
12 Mar, 2019
(Expiration: Jun, 2029)
|
STRAWMAN
| |
| EP2337849B1 | Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production | UNIQURE BIOPHARMA BV |
12 Mar, 2019
(Expiration: Sep, 2029)
|
WEINZIERL
(and 4 more)
| |
| EP2772245B1 | Ginger Extract For The Protection Of Stem Cells | SYMRISE |
07 Mar, 2019
|
FLAVEX NATUREXTRAKTE
| |
| EP2658517B2 | Improved Powderous Vitamin E Formulations | DSM ASSETS |
06 Mar, 2019
|
BASF
| |
| EP2515887B1 | Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine | UCB BIOPHARMA |
06 Mar, 2019
|
GENERICS UK
(and 1 more)
| |
| EP3062761B1 | Two-Phase Composition Comprising A Fatty Acid Ester Of Sugar Or A Liquid Alkyl Polyglucoside, With An Hlb<8, And A C8-C18 Branched Alkane | LOREAL |
06 Mar, 2019
|
HENKEL
| |
| EP2482849B1 | Combination Immunotherapy For The Treatment Of Cancer | UNIVERSITY OF TEXAS SYSTEM |
06 Mar, 2019
(Expiration: Sep, 2030)
|
KYMAB
(and 1 more)
| |
| EP2782559B1 | Pharmaceutical Composition Comprising Myo-Inositol And D-Chiro-Inositol | LO LI PHARMA |
06 Mar, 2019
|
VERCO
| |
| EP2925299B1 | Novel Pharmaceutical Composition | NOVARTIS AG |
05 Mar, 2019
(Expiration: Nov, 2033)
|
GENERICS UK
| |
| EP2774606B1 | Pharmaceutical Composition Comprising Ivabradine Hydrochloride Polymorph Iv | SYNTHON BV |
05 Mar, 2019
(Expiration: Feb, 2034)
|
NEIDLEIN
(and 4 more)
| |
| EP2970101B1 | Prodrugs Of Fumarates And Their Use In Treating Various Deseases | ALKERMES PHARMA IRELAND |
05 Mar, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 2 more)
| |
| EP2475432B2 | Cosmetic Composition With An Antimicrobial Effect | DALLI WERKE |
01 Mar, 2019
|
BEIERSDORF
(and 1 more)
| |
| EP2482822B1 | Orally Administered Corticosteroid Compositions | ADARE PHARMACEUTICALS INC |
01 Mar, 2019
(Expiration: Sep, 2030)
|
DR FALK PHARMA
| |
| EP2768322B1 | Whey Protein Micelles Against Muscle Atrophy And Sarcopenia | SOCIT DES PRODUITS NESTL |
28 Feb, 2019
|
ARLA FOODS AMBA
(and 1 more)
| |
| EP1942939B2 | Interleukin-13 Antibody Composition | MEDIMMUNE |
28 Feb, 2019
|
DERMIRA
| |
| EP2680885B8 | Combination Vaccines With Lower Doses Of Antigen And/Or Adjuvant | GLAXOSMITHKLINE BIOLOGICALS SA |
28 Feb, 2019
(Expiration: Mar, 2032)
|
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
| |
| EP2417199B1 | Volatile Oily Composition | BIOSYNTHIS |
28 Feb, 2019
|
HENKEL
| |
| EP1736139B1 | Hair-Treating Agent And Methods Of Treating Hair | KAO |
28 Feb, 2019
|
HENKEL
| |
| EP2914296B2 | Treatment Of Cancers Using Pi3 Kinase Isoform Modulators | INFINITY PHARMACEUTICALS |
28 Feb, 2019
|
HEXAL
| |
| EP2844667B1 | Targeted/Immunomodulatory Fusion Proteins And Methods For Making Same | BIOCON |
28 Feb, 2019
|
HOFFMANN EITLE
| |
| EP3030218B1 | Gel-Like Sun Protection Product Containing Fatty Alcohols | BEIERSDORF |
28 Feb, 2019
|
LORAL
| |
| EP2616099B1 | Immunogenic Compositions | GLAXOSMITHKLINE BIOLOGICALS SA |
28 Feb, 2019
(Expiration: Sep, 2031)
|
PFIZER
| |
| EP2461802B2 | Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture Thereof | SOFAR |
28 Feb, 2019
|
TILLOTTS PHARMA
| |
| EP2444057B1 | Hair Treatment Agent With A High Proportion Of Bound Water | BEIERSDORF |
27 Feb, 2019
|
HENKEL
| |
| EP2509565B1 | Emulsifier-Free, Polymer-Stabilized Foam Formulations | NEUBOURG SKIN CARE GMBH AND CO KG |
26 Feb, 2019
(Expiration: Dec, 2030)
|
HENKEL
| |
| EP2654789B1 | Antibodies Against Human Cd39 And Use Thereof | OREGA BIOTECH |
26 Feb, 2019
|
TIZONA THERAPEUTICS
(and 3 more)
| |
| EP2691112B1 | Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd-1 And Related Treatments | MERCK SHARP & DOHME |
25 Feb, 2019
|
KNIG SZYNKA TILMANN VON RENESSE
(and 1 more)
| |
| EP3131582B1 | Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated Diseases | VERTEX PHARMACEUTICALS INCORPORATED |
22 Feb, 2019
|
GENERICS UK
| |
| EP2296758B1 | Hair Conditioning Composition Comprising Three Kinds Of Silicones | UNILEVER |
22 Feb, 2019
|
HENKEL
| |
| EP3129106B2 | Compositions And Dispersions Containing Particles Comprising A Polymer | LOREAL |
22 Feb, 2019
|
HENKEL
| |
| EP3072398B1 | Bifidobacterium Longum And Hippocampal Bdnf Expression | NESTEC SA |
22 Feb, 2019
(Expiration: Apr, 2029)
|
MORINAGA MILK INDUSTRY
| |
| EP2659892B1 | Concomitant Drug For Improving Cognitive Function | NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE |
22 Feb, 2019
|
NUTRICIA
| |
| EP2575776B1 | Process For Making Dry And Stable Hemostatic Compositions | BAXTER HEALTHCARE SA |
21 Feb, 2019
(Expiration: Jun, 2031)
|
FERROSAN MEDICAL DEVICES
(and 1 more)
| |
| EP2772480B2 | Hiv Replication Inhibitor | SHIONOGI |
21 Feb, 2019
|
HIVIH
| |
| EP2815753B1 | Oral Pharmaceutical Composition | TAIHO PHARMACEUTICAL |
18 Feb, 2019
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2658509B1 | Hair Colouring Composition | KAO GERMANY GMBH |
15 Feb, 2019
(Expiration: Dec, 2031)
|
HENKEL
| |
| EP3023095B2 | Direct Compression Formulation And Process | NOVARTIS AG |
15 Feb, 2019
(Expiration: Jan, 2025)
|
INTAS PHARMACEUTICALS
(and 2 more)
| |
| EP2970484B2 | Heterodimeric Bispecific Antibodies | AMGEN |
15 Feb, 2019
|
RICKER
| |
| EP2068846B1 | Foaming Granule And Method For Making Same | THE ANDERSONS |
08 Feb, 2019
|
BAYER
| |
| EP1768646B1 | Cosmetic Sprays | UNILEVER PLC |
08 Feb, 2019
(Expiration: May, 2025)
|
HENKEL
| |
| EP3003330B1 | Microbiota Restoration Therapy (Mrt), Compositions And Methods Of Manufacture | REBIOTIX INC |
08 Feb, 2019
(Expiration: Jun, 2034)
|
STRAWMAN
| |
| EP2833909B1 | Pcv/Mycoplasma Hyopneumoniae/Prrs Combination Vaccine | ZOETIS SERVICES |
07 Feb, 2019
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP1956014B1 | Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same | TEIJIN PHARMA LTD |
06 Feb, 2019
(Expiration: Jun, 2019)
|
DR SCHN
| |
| EP3113632B1 | Liquid Lactase Compositions | DSM ASSETS |
04 Feb, 2019
|
CHR HANSEN
| |
| EP3086761B1 | Aqueous Cosmetic Composition Comprising Alkylcellulose, Non-Volatile Oils, A Hydrophilic Gelling Polymer And A Polyol | LOREAL SA |
04 Feb, 2019
(Expiration: Dec, 2034)
|
HENKEL
| |
| EP2822591B1 | Pharmaceutical Formulations Of Tnf-Alpha Antibodies | CADILA HEALTHCARE LTD |
01 Feb, 2019
(Expiration: Mar, 2033)
|
GRNECKER PATENT UND RECHTSANWLTE PARTG MBB
(and 1 more)
| |
| EP2374472B9 | Compositions And Methods For Treating Ophthalmic Disorders | DYAX CORP |
01 Feb, 2019
(Expiration: Mar, 2027)
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
(and 2 more)
| |
| EP2849723B1 | High-Concentration Monoclonal Antibody Formulations | GENENTECH |
31 Jan, 2019
|
BAYER BAYER
| |
| EP2822383B1 | Antimicrobial Compostion Containing Lauric Acid And Method For Their Production | CARGILL INC |
31 Jan, 2019
(Expiration: Mar, 2033)
|
NUTRITION SCIENCES
(and 1 more)
| |
| EP2687106B1 | High Energy Liquid Enteral Nutritional Composition | NUTRICIA NV |
30 Jan, 2019
(Expiration: Dec, 2028)
|
FRESENIUS KABI DEUTSCHLAND
(and 2 more)
| |
| EP2618833B1 | Breast Cancer Therapeutics | IMBA INSTITUT FUR MOLEKULARE BIOTECHONOLOGIE GMBH |
28 Jan, 2019
(Expiration: Sep, 2031)
|
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
(and 1 more)
| |
| EP2603100B1 | Dry Storage Stabilizing Composition For Biological Materials | ADVANCED BIONUTRTION CORP |
25 Jan, 2019
(Expiration: Aug, 2031)
|
CHR HANSEN
| |
| EP2526963B1 | Solution Preparation Containing Stabilized Antibody | CHUGAI PHARMACEUTICAL CO LTD |
25 Jan, 2019
(Expiration: Jan, 2031)
|
HEXAL SANDOZ
| |
| EP2403520B1 | Insulin Formulations For Rapid Uptake | ELI LILLY AND CO |
25 Jan, 2019
(Expiration: Mar, 2030)
|
MAIKOWSKI & NINNEMANN PATENTANWLTE PARTNERSCHAFT MBB
(and 1 more)
| |
| EP2355902B1 | Nutritional Compositions With Coated Lipid Globules | NUTRICIA NV |
24 Jan, 2019
(Expiration: Dec, 2029)
|
ABBOTT LABORATORIES
(and 1 more)
| |
| EP3119385B2 | Composition Comprising Cinnamaldehyde And Zinc To Improve Swallowing | SOCIT DES PRODUITS NESTL |
24 Jan, 2019
|
NUTRICIA
| |
| EP2592950B2 | Isomaltulose For Use In Enhancing Mental Performance | SDZUCKER MANNHEIMOCHSENFURT |
23 Jan, 2019
|
NUTRICIA
| |
| EP2956129B1 | Pharmaceutical Compositions Containing Dexketoprofen And Tramadol | LABORATORIOS MENARINI |
18 Jan, 2019
|
HOFFMANN EITLE
(and 1 more)
| |
| EP3022231B1 | Cyclodextrin | CURADEV PHARMA PVT |
18 Jan, 2019
|
LIGAND PHARMACEUTICALS INCORPORATED
| |
| EP2033627B2 | Use Of A Bifidobacterium Species Lysate For Treating Sensitive Skin | LOREAL |
18 Jan, 2019
|
NUTRICIA
| |
| EP2858985B1 | Crystalline Forms Of An Androgen Receptor Modulator | ARAGON PHARMACEUTICALS |
18 Jan, 2019
|
SAGITTARIUS
(and 2 more)
| |
| EP3222266B1 | Compositions And Methods For Targeted Thermomodulation | SIENNA BIOPHARMACEUTICALS INC |
18 Jan, 2019
(Expiration: Aug, 2031)
|
SEBACIA
| |
| EP2081550B2 | Coating Capsules With Active Pharmaceutical Ingredients | RELIANT PHARMACEUTICALS |
17 Jan, 2019
|
DEHMEL & BETTENHAUSEN
(and 1 more)
| |
| EP2792369B1 | Bendamustine Cyclopolysaccharide Compositions | SOFTKEMO PHARMA |
17 Jan, 2019
|
INTAS PHARMACEUTICALS
| |
| EP1710259B1 | Cosmetic Composition Thickened With An Inverse Latex | SOCIETE DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC SA |
17 Jan, 2019
(Expiration: Jan, 2019)
|
SNF
| |
| EP1810026B1 | B7-H1 And Methods Of Diagnosis, Prognosis, And Treatment Of Cancer | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
16 Jan, 2019
|
MERCK SHARP & DOHME
(and 1 more)
| |
| EP3112377B1 | Bifunctional Polypeptides | IMMUNOCORE LTD |
15 Jan, 2019
(Expiration: May, 2030)
|
MICHALSKI HTTERMANN & PARTNER PATENTANWLTE MBB
| |
| EP2789659B2 | Photoluminescent Pigment; Cosmetic, Paint Composition, And Resin Composition Containing Same; And Photoluminescent Pigment Production Method | NIPPON SHEET GLASS |
11 Jan, 2019
|
BASF COLORS & EFFECTS
| |
| EP3021824B2 | Antiperspirant Spray Devices And Compositions | THE PROCTER & GAMBLE |
11 Jan, 2019
|
BEIERSDORF
(and 1 more)
| |
| EP3021825B1 | Antiperspirant Spray Devices And Compositions | THE PROCTER & GAMBLE |
11 Jan, 2019
|
BEIERSDORF
| |
| EP2283803B2 | Two-Part Foam Hair Dye | KAO |
11 Jan, 2019
|
HENKEL
| |
| EP2648520B1 | Dexmedetomidine Premix Formulation | HOSPIRA INC |
09 Jan, 2019
(Expiration: Jun, 2032)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP2552424B1 | Process For Preparing Carrier Particles For Dry Powders For Inhalation | CHIESI FARMACEUTICI |
08 Jan, 2019
|
ZBM PATENTS ZEA
(and 1 more)
| |
| EP2459163B1 | Skin Protectant, Particularly Against Hydrophobic (Lipohilic) And Against Hydrophilic (Lipophobic) Harmful Substances | DEB |
04 Jan, 2019
|
BEIERSDORF
| |
| EP2852375B1 | Method Of Treating Hair | UNILEVER |
04 Jan, 2019
|
LOREAL
| |
| EP2670429B1 | Method For Inactivation/Removal Of Coagulation Factors By Precipitation | OCTAPHARMA AG |
04 Jan, 2019
(Expiration: Feb, 2032)
|
STRAWMAN
(and 1 more)
| |
| EP3021830B1 | Compositions And Methods For Treating Hair | LOREAL |
03 Jan, 2019
|
BEIERSDORF
| |
| EP2622971B1 | Method For Controlling The Digestive Coagulation Of Proteins | NUTRICIA NV |
03 Jan, 2019
(Expiration: Apr, 2030)
|
NESTEC
(and 2 more)
| |
| EP2575775B1 | Process For Making Dry And Stable Hemostatic Compositions | BAXTER HEALTHCARE SA |
02 Jan, 2019
(Expiration: Jun, 2031)
|
FERROSAN MEDICAL DEVICES
(and 1 more)
| |
| EP2934515B1 | Pharmaceutical Combination Comprising Binimetinib | NOVARTIS AG |
02 Jan, 2019
(Expiration: Dec, 2033)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP2530091B1 | Anti-Dll3 Antibody | CHUGAI SEIYAKU KABUSHIKI KAISHA |
02 Jan, 2019
|
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 2 more)
|